AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 279: H1071-H1078, 2000;
0363-6135/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrison, R. R.
Right arrow Articles by Matherne, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrison, R. R.
Right arrow Articles by Matherne, G. P.
Vol. 279, Issue 3, H1071-H1078, September 2000

Transgenic overexpression of cardiac A1 adenosine receptors mimics ischemic preconditioning

R. Ray Morrison1, Rachael Jones1, Anne M. Byford1, Alyssa R. Stell1, Jason Peart2, John P. Headrick2, and G. Paul Matherne1

1 Department of Pediatrics and the Cardiovascular Research Center, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, and 2 The Rotary Center for Cardiovascular Research, Griffith University Gold Coast Campus, Southport, Q 4217 Australia

The role of A1 adenosine receptors (A1AR) in ischemic preconditioning was investigated in isolated crystalloid-perfused wild-type and transgenic mouse hearts with increased A1AR. The effect of preconditioning on postischemic myocardial function, lactate dehydrogenase (LDH) release, and infarct size was examined. Functional recovery was greater in transgenic versus wild-type hearts (44.8 ± 3.4% baseline vs. 25.6 ± 1.7%). Preconditioning improved functional recovery in wild-type hearts from 25.6 ± 1.7% to 37.4 ± 2.2% but did not change recovery in transgenic hearts (44.8 ± 3.4% vs. 44.5 ± 3.9%). In isovolumically contracting hearts, pretreatment with selective A1 receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine attenuated the improved functional recovery in both wild-type preconditioned (74.2 ± 7.3% baseline rate of pressure development over time untreated vs. 29.7 ± 7.3% treated) and transgenic hearts (84.1 ± 12.8% untreated vs. 42.1 ± 6.8% treated). Preconditioning wild-type hearts reduced LDH release (from 7,012 ± 1,451 to 1,691 ± 1,256 U · l-1 · g-1 · min-1) and infarct size (from 62.6 ± 5.1% to 32.3 ± 11.5%). Preconditioning did not affect LDH release or infarct size in hearts overexpressing A1AR. Compared with wild-type hearts, A1AR overexpression markedly reduced LDH release (from 7,012 ± 1,451 to 917 ± 1,123 U · l-1 · g-1 · min-1) and infarct size (from 62.6 ± 5.1% to 6.5 ± 2.1%). These data demonstrate that murine preconditioning involves endogenous activation of A1AR. The beneficial effects of preconditioning and A1AR overexpression are not additive. Taken with the observation that A1AR blockade equally eliminates the functional protection resulting from both preconditioning and transgenic A1AR overexpression, we conclude that the two interventions affect cardioprotection via common mechanisms or pathways.

mouse; heart; lactose dehydrogenase; infarct size


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Morrison, B. Teng, P. J. Oldenburg, L. C. Katwa, J. B. Schnermann, and S. J. Mustafa
Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1875 - H1882.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. R. Lankford, J.-N. Yang, R. Rose'Meyer, B. A. French, G. P. Matherne, B. B. Fredholm, and Z. Yang
Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1469 - H1473.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. Peart and J. P Headrick
Adenosine-mediated early preconditioning in mouse: protective signaling and concentration dependent effects
Cardiovasc Res, June 1, 2003; 58(3): 589 - 601.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. E. Regan, M. Broad, A. M. Byford, A. R. Lankford, R. J. Cerniway, M. W. Mayo, and G. P. Matherne
A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity
Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H859 - H866.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. J Ashton, K. Holmgren, J. Peart, A. R Lankford, G Paul Matherne, S. Grimmond, and J. P Headrick
Effects of A1 adenosine receptor overexpression on normoxic and post-ischemic gene expression
Cardiovasc Res, March 1, 2003; 57(3): 715 - 726.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
A. R. Lankford, A. M. Byford, K. J. Ashton, B. A. French, J. K. Lee, J. P. Headrick, and G. P. Matherne
Gene expression profile of mouse myocardium with transgenic overexpression of A1 adenosine receptors
Physiol Genomics, October 29, 2002; 11(2): 81 - 89.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Headrick, R. Lasley, E. Kilpatrick, P. Narayan, and R. Mentzer Jr.
Apparent Activation of Cardiovascular A1 Adenosine Receptors by A3 Agonists
Am J Physiol Heart Circ Physiol, February 1, 2002; 282 (2): H793 - H796.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
G. J Harrison, R. J Cerniway, J. Peart, S. S Berr, K. Ashton, S. Regan, G Paul Matherne, and J. P Headrick
Effects of A3 adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart
Cardiovasc Res, January 1, 2002; 53(1): 147 - 155.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. J. Cerniway, Z. Yang, M. A. Jacobson, J. Linden, and G. P. Matherne
Targeted deletion of A3 adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium
Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1751 - H1758.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. Mubagwa and W. Flameng
Adenosine, adenosine receptors and myocardial protection: An updated overview
Cardiovasc Res, October 1, 2001; 52(1): 25 - 39.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. Peart, G. Paul Matherne, R. J. Cerniway, and J. P. Headrick
Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart
Cardiovasc Res, October 1, 2001; 52(1): 120 - 129.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Headrick, N. S. Gauthier, R. Morrison, and G. P. Matherne
Cardioprotection by KATP channels in wild-type hearts and hearts overexpressing A1-adenosine receptors
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1690 - H1697.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Morrison, M. A. H. Talukder, C. Ledent, and S. J. Mustafa
Cardiac effects of adenosine in A2A receptor knockout hearts: uncovering A2B receptors
Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H437 - H444.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Yang, R. J. Cerniway, A. M. Byford, S. S. Berr, B. A. French, and G. P. Matherne
Cardiac overexpression of A1-adenosine receptor protects intact mice against myocardial infarction
Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H949 - H955.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online